Stryker Corporation is a global medical technology company offering innovative products in MedSurg, Neurotechnology, and Orthopaedics. Key products include surgical equipment, endoscopic systems, patient handling equipment, Mako robotic-arm assisted technology, joint replacement implants, neurovascular devices, and AI-assisted virtual care platforms. Products are sold in approximately 61 countries, serving doctors, hospitals, and healthcare facilities, impacting more than 150 million patients annually.
expected 2026-10-29
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | SYK | discussed Artificial Intelligence | |
| topic_mention | SYK | discussed Regulation | |
| topic_mention | SYK | discussed Healthcare & Bio | |
| topic_mention | SYK | discussed Semiconductor | |
| topic_mention | SYK | discussed Supply Chain | |
| topic_mention | SYK | discussed Regulation | |
| topic_mention | SYK | discussed Sovereign & Government | |
| topic_mention | SYK | discussed Healthcare & Bio | |
| metric | SYK gross margin | reported $14.3 percent | |
| guidance | SYK | guided guidance reiterates our previous guidance inclusive of dilution from the Inari acquisition while also offsetting a tariff impact of approximately $200 million | |
| outlook | SYK | stated We expect our adjusted net earnings per diluted share (2) to be the range of $13 | |
| outlook | SYK | stated We believe these non-GAAP financial measures provide meaningful information to assist investors and shareholders in understanding our financial results and asse | |
| topic_mention | SYK | discussed Semiconductor | |
| topic_mention | SYK | discussed Supply Chain | |
| topic_mention | SYK | discussed Regulation | |
| topic_mention | SYK | discussed Sovereign & Government | |
| topic_mention | SYK | discussed Healthcare & Bio | |
| metric | SYK gross margin | reported $18.7 percent | |
| outlook | SYK | stated We believe these non-GAAP financial measures provide meaningful information to assist investors and shareholders in understanding our financial results and asse | |
| topic_mention | SYK | discussed Artificial Intelligence |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-11 | 2025-12-31 | 0000310764-26-000010 | EDGAR | 50K words |
| 2025-02-12 | 2024-12-31 | 0000310764-25-000023 | EDGAR | — |
| 2024-02-14 | 2023-12-31 | 0000310764-24-000024 | EDGAR | — |
| 2023-02-10 | 2022-12-31 | 0000310764-23-000017 | EDGAR | — |
| 2022-02-11 | 2021-12-31 | 0000310764-22-000028 | EDGAR | — |
| 2021-02-11 | 2020-12-31 | 0000310764-21-000027 | EDGAR | — |
| 2020-02-06 | 2019-12-31 | 0000310764-20-000014 | EDGAR | — |
| 2019-02-07 | 2018-12-31 | 0000310764-19-000014 | EDGAR | — |
| 2018-02-08 | 2017-12-31 | 0000310764-18-000031 | EDGAR | — |
| 2017-02-09 | 2016-12-31 | 0000310764-17-000034 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-31 | 2026-06-30 | 0000310764-26-000050 | EDGAR | — |
| 2026-05-11 | 2026-03-31 | 0000310764-26-000031 | EDGAR | — |
| 2025-10-31 | 2025-09-30 | 0000310764-25-000129 | EDGAR | 19K words |
| 2025-08-01 | 2025-06-30 | 0000310764-25-000107 | EDGAR | — |
| 2025-05-02 | 2025-03-31 | 0000310764-25-000075 | EDGAR | — |
| 2024-10-30 | 2024-09-30 | 0000310764-24-000115 | EDGAR | — |
| 2024-07-31 | 2024-06-30 | 0000310764-24-000098 | EDGAR | — |
| 2024-05-01 | 2024-03-31 | 0000310764-24-000064 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0000310764-23-000116 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0000310764-23-000106 | EDGAR | — |
| 2023-05-02 | 2023-03-31 | 0000310764-23-000067 | EDGAR | — |
| 2022-11-01 | 2022-09-30 | 0000310764-22-000105 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-30 | 0000310764-26-000048 | EDGAR | — |
| 2026-06-26 | 0000310764-26-000041 | EDGAR | — |
| 2026-05-20 | 0001193125-26-232643 | EDGAR | — |
| 2026-05-08 | 0000310764-26-000029 | EDGAR | — |
| 2026-04-30 | 0000310764-26-000025 | EDGAR | — |
| 2026-03-23 | 0001193125-26-118634 | EDGAR | 2K words |
| 2026-03-12 | 0001193125-26-104431 | EDGAR | — |
| 2026-03-11 | 0001193125-26-102460 | EDGAR | — |
| 2026-01-29 | 0000310764-26-000006 | EDGAR | — |
| 2025-12-04 | 0001193125-25-308097 | EDGAR | — |
178 total filings indexed. 146 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | SYK Earnings Call Transcript | |
| — | SYK Earnings Call Transcript | |
| — | SYK Earnings Call Transcript | |
| — | SYK Earnings Call Transcript | |
| — | SYK Earnings Call Transcript | |
| — | SYK Earnings Call Transcript | |
| — | SYK Earnings Call Transcript | |
| — | Q9 FY2025 | SYK Q9 FY2025 Earnings Call Transcript |
| — | SYK Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0000310764 |
| Ticker | SYK |
| Exchange | NYSE |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | MI |
| Website | https://www.stryker.com |
| Listed | 1979-05-02 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SYK (~200 tokens, structured JSON with cryptographic provenance)